This inventor holds 1 USPTO granted patent and 3 published patent applications and 3 EPO patents. Top assignee: Small Pharma Ltd. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Richard Myerson: Innovator in Pharmaceutical Chemistry
Introduction
Richard Myerson is a notable inventor based in Derbyshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on hydroxynorketamine. His research focuses on developing stable and processable salt forms of this compound, which has implications for medical applications.
Latest Patents
Richard Myerson holds a patent for "Crystalline forms of hydroxynorketamine." This invention provides novel, stable, processable, and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility. This advancement is crucial for enhancing the efficacy and delivery of the compound in therapeutic settings.
Career Highlights
Myerson is associated with Small Pharma Ltd, where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to improving drug formulations and ensuring their effectiveness in clinical applications.
Collaborations
Throughout his career, Richard has collaborated with talented professionals, including David Pearson and Lorraine Sharp. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Richard Myerson's contributions to pharmaceutical chemistry, particularly through his patent on hydroxynorketamine, highlight his role as an innovator in the field. His work at Small Pharma Ltd and collaborations with esteemed colleagues further underscore his commitment to advancing medical science.